###begin article-title 0
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Overexpression of Aurora-A and mutant Ras (RasV12) together has been detected in human bladder cancer tissue. However, it is not clear whether this phenomenon is a general event or not. Although crosstalk between Aurora-A and Ras signaling pathways has been reported, the role of these two genes acting together in tumorigenesis remains unclear.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 424 428 424 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 307 312 <span type="species:ncbi:10090">mouse</span>
Real-time PCR and sequence analysis were utilized to identify Ha- and Ki-ras mutation (Gly -> Val). Immunohistochemistry staining was used to measure the level of Aurora-A expression in bladder and colon cancer specimens. To reveal the effect of overexpression of the above two genes on cellular responses, mouse NIH3T3 fibroblast derived cell lines over-expressing either RasV12and wild-type Aurora-A (designated WT) or RasV12 and kinase-inactivated Aurora-A (KD) were established. MTT and focus formation assays were conducted to measure proliferation rate and focus formation capability of the cells. Small interfering RNA, pharmacological inhibitors and dominant negative genes were used to dissect the signaling pathways involved.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 186 190 186 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 427 431 427 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Overexpression of wild-type Aurora-A and mutation of RasV12 were detected in human bladder and colon cancer tissues. Wild-type Aurora-A induces focus formation and aggregation of the RasV12 transformants. Aurora-A activates Ral A and the phosphorylation of AKT as well as enhances the phosphorylation of MEK, ERK of WT cells. Finally, the Ras/MEK/ERK signaling pathway is responsible for Aurora-A induced aggregation of the RasV12 transformants.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
Wild-type-Aurora-A enhances focus formation and aggregation of the RasV12 transformants and the latter occurs through modulating the Ras/MEK/ERK signaling pathway.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 456 461 <span type="species:ncbi:9606">human</span>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
###xml 851 856 <span type="species:ncbi:9606">human</span>
The role of Aurora-A, a serine/threonine kinase, in tumorigenesis has been reported [1-4]. In proliferative cells, the expression levels of Aurora-A mRNA and protein are low during G1 and S phases. The levels peak at G2 phase and fall during mitotic exit and G1 phase of the next cell cycle [3,5]. Aurora-A protein consists of 403 amino acids and has a molecular weight of 46 kilo Daltons (kDa) [5]. Overexpression of Aurora-A has been detected in several human cancer cell lines and cancers of the following tissues: bladder, breast, colon, liver, gingival, gliomas, medulloblastoma, ovarian, pancreas, prostate and tongue [6-16]. Ectopic expression of Aurora-A in mouse NIH3T3 cells and Rat1 fibroblasts causes centrosome amplification and cell transformation [8,17]. This suggests that Aurora-A gene amplification and overexpression play a role in human carcinogenesis, largely due to the effect of Aurora-A on oncogenic cell growth, rather than a loss of maintenance of centrosomal or chromosomal integrity.
###end p 10
###begin p 11
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras-</italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Ras proteins are important for controlling the activities of several crucial signaling pathways. The ras-gene encoded proteins become constitutively active due to point mutations in their coding sequences, especially at amino acid 12, 13, and 61 [18]. These activated Ras proteins contribute significantly to several aspects of the malignant phenotype, including deregulation of tumor-cell growth, programmed cell death, invasiveness, and induction of new blood-vessel formation [19].
###end p 11
###begin p 12
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 258 264 258 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">val12 </sup>
###xml 438 440 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 441 443 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 587 589 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 590 592 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 751 757 747 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos </italic>
###xml 767 769 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 770 772 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 886 888 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 582 585 <span type="species:ncbi:9860">Elk</span>
###xml 613 616 <span type="species:ncbi:9860">Elk</span>
Various Ras-regulated signaling pathways are responsible for cell survival, transformation, and apoptosis [20,21]. Multiple effectors have been found downstream of Ras, including Raf, PI3K, RalGDS, RIN1, MEKK, GAP, NF1, and AF6 [21]. Overexpression of Ha-rasval12 oncogene not only transforms NIH3T3 cells but also sensitizes them to various stresses, such as serum depletion, Lovastatin, tumor necrosis factor-alpha and 5-FU treatments [22-26]. Through the Ras/Raf interaction, Raf activates MEK1/2, which subsequently phosphorylates ERK1/2 and activates the transcription factor, Elk [27,28]. After activation, Elk complexes with the serum responsive factor (SRF) and binds to the serum responsive element (SRE) which is an important element in the c-fos promoter [29-31]. RalGDS, another Ras effector, associates with Ras and activates Ral (a small GTPase), including RalA and RalB [32].
###end p 12
###begin p 13
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus </italic>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus </italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 776 779 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 46 53 <span type="species:ncbi:8355">Xenopus</span>
###xml 108 115 <span type="species:ncbi:8355">Xenopus</span>
Studies on progesterone-induced maturation of Xenopus oocytes indicate that overexpression of kinase Eg2, a Xenopus member of the Aurora/Ipl1 family, activates the MAP kinase pathway [33]. This study raises the possibility that Aurora protein may also transduce cell transformation signals through the MAPK signaling pathway. In addition, Aurora-A could associate with NM23-H1, which may phosphorylates the scaffold kinase repressor of Ras (KSR) [34-36]. Gigoux et al., (2002) reported that the interaction between Aurora-A and RasGAP, a negative Ras regulator, decreased the kinase activity of Aurora-A [37]. Wu et al., (2005) found that RalGDS and RalA are downstream substrates of Aurora-A [38]. Tatsuka et al., (2005) showed that overexpression of Aurora-A potentiated Ha-ras-mediated oncogenic transformation by increasing focus formation [39]. Furukawa et al., (2006) showed that Aurora-A is one of the downstream targets of MAPK signaling [40]. These observations imply some degree of crosstalk between Aurora-A and Ras signaling pathways.
###end p 13
###begin p 14
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
In this study, the collective role of Aurora-A and Ha-ras in cell aggregation was unraveled. The possible signaling pathways involved were also investigated.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Tumor Tissues
###end title 16
###begin p 17
###xml 131 139 <span type="species:ncbi:9606">patients</span>
The cancer tissues from National Cheng Kung University Hospital between 2001 and 2004 were eligible for analysis. Consent from the patients was obtained, and the study was approved by the institutional review board.
###end p 17
###begin title 18
Genomic DNA preparation
###end title 18
###begin p 19
The tissues were homogenized with a mortar and a pestle in the presence of liquid nitrogen, followed by phenol/chloroform extraction. After ethanol precipitation, genomic DNA was dissolved in TE buffer.
###end p 19
###begin title 20
Detection of Ha- and Ki-ras codon 12 mutation
###end title 20
###begin p 21
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
Detection of Ha-ras codon 12 mutation was conducted using a commercial SNP system (ABI, USA) [41]. Detection of Ki-ras codon 12 mutation was conducted using a commercial SNP system following the manufacturer's instructions [42] (Roche, Germany).
###end p 21
###begin title 22
Plasmids
###end title 22
###begin p 23
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
The wild-type and catalytic-inactive mutant Aurora-A genes were cloned into pEGFPN1 plasmid (pEGFP-Aurora-A-WT and pEGFP-Aurora-A-KD). The construction of pHARalAS183A and pHARalS194A was described previously [38].
###end p 23
###begin title 24
Cell lines and culture
###end title 24
###begin p 25
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 486 488 480 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 443 447 <span type="species:ncbi:9913">calf</span>
The NIH3T3 cell harbors the inducible Ha-rasV12 oncogene (pSVlacO ras) designated as 7-4 [22]. The stable cell lines Vector, WT and KD were derivatives of 7-4 cells containing GFP (pEGFPN1), wild-type GFP-Aurora-A (pEGFP-Aurora-A- WT) as well as kinase-inactivated GFP-Aurora-A (pEGFP-Aurora-A-KD), respectively. All the fibroblast stable cell lines were maintained in Dulbecco's modified Eagle medium (DMEM; GIBCO, USA) supplemented with 10% calf serum (GIBCO) at 37degreesC in a 5% CO2 incubator.
###end p 25
###begin title 26
Immunohistochemical (IHC) staining
###end title 26
###begin p 27
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 175 177 175 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
Tissue sections of paraffin embedded specimens on the slides after deparaffinization and rehydration. Then, the slides were soaked in 1x PBS for 5 min and immersed in 1.6% H2O2 (in methanol) for 5 min at room temperature (RT). After rinsing with 1x PBS, the slides were incubated with boiling citric acid (10 mM) twice for 5 min and the slides were rinsed with 1x PBS. Then, the specimens were incubated with primary antibody at 4degreesC for overnight. On the second day, the slides were rinsed 3 times for 5 min with 1XPBS. Then, the slides were incubated with biotinylated secondary antibody (DakoCytomation, LSAB2 System-HRP, USA) for 10 min at RT. After rinsing the slides 3 times for 5 min with 1x PBS Streptavidin reagent (DakoCytomation) was applied to cover the specimens for 10 min at RT. The slides were rinsed again 3 times for 5 min with 1x PBS. AEC solution (DakoCytomation) was added to cover specimens for 10 min at RT. The specimens were rinsed gently with distilled water and counter stained with 10% hematoxylin. Finally, the slides were rinsed gently with distilled water and mounted.
###end p 27
###begin title 28
Establishment of stable cell lines
###end title 28
###begin p 29
###xml 189 190 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 213 215 212 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 499 500 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
After seeding cells on the culture plate for overnight, the medium was replaced with fresh medium. The desired plasmid DNA precipitated with ethanol was resuspended with 40 mul of sterile H2O. Then, 0.5 ml of CaCl2 (pH 7.9) solution was mixed with the DNA solution, transferred into a 3 ml tube and mixed with 0.5 ml of HEPES buffer (pH 7.1). The calcium-DNA solution was transferred into the cell culture plate and the cells were further incubated at 37degreesC in a humidified incubator with 5% CO2. Six hours after incubation, the medium was replaced with medium containing serum and incubated for another 24 hr. The cells were then treated with the antibiotic G418 (Sigma, USA) to select for drug-resistant cell lines. Within 10 to 14 days, the cells containing the antibiotic resistance gene formed colonies, which were selected, propagated and analyzed for transgene expression by Western blotting.
###end p 29
###begin title 30
Cell growth assay
###end title 30
###begin p 31
Cell growth was determined by MTT assay. The cells (1 x 103/well) were plated in 96-well plates. After incubation with or without IPTG (2.5 mM) for the indicated times, the cells were treated with 10 mul of MTT solution (5 mg/ml, Sigma, USA) and incubated for another 3 h at 37degreesC. Finally, 100 mul DMSO were added to lyses the cells, the absorbance of the cell lysates was measured at 540 nm by a Dynatech Mr 5000 microplate reader (Dynatech laboratories, USA).
###end p 31
###begin title 32
Focus formation assay
###end title 32
###begin p 33
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 516 517 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The cells (5 x 102) were plated on 10 cm plates with or without IPTG (2.5 mM). Media with or without IPTG were changed every 3-4 days for 2 weeks. The cells were washed twice, and then fixed with 4% paraformaldehyde for 10 min at 37degreesC. The paraformaldehyde was then aspirated from the plates, and washed twice with 1x PBS. Giemsa solution (Sigma, USA) was added to cover the bottom of the plate. After incubation at RT for 5 min, Giemsa solution was poured off, and the plates were rinsed in double distilled H20 until excess color ceased coming off. The plates were dried at RT and the foci were counted.
###end p 33
###begin title 34
RalA pull-down assay
###end title 34
###begin p 35
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 300 316 292 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 510 512 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 513 515 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 300 316 <span type="species:ncbi:562">Escherichia coli</span>
The cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 5 mM MgCl2, 1% Nonidet P-40, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride). Total cell lysates (500 mug) were incubated for 1 h at 4degreesC with 50 mul of glutathione beads (Sigma, USA) coated with GST-RalBD that had been produced in Escherichia coli. Then, the beads were washed three times with lysis buffer and boiled in the sample buffer. Samples were resolved on a 12% SDS-PAGE, followed by Western blot analysis using anti-RalA antibody [43,44].
###end p 35
###begin title 36
Western blot analysis
###end title 36
###begin p 37
Cell lysates (50 mug) were subjected to 12% SDS-PAGE and subsequently transferred to a PVDF membrane (Millipore, USA). The membranes were blocked with 5% non-fat milk for 1 h at RT. The membranes were washed with anti-Aurora-A (Transduction, BD, Germany), anti-AKT (Cell signaling technology), anti-p-AKT(Thr308) (Cell signaling technology), anti-Ras (Oncogene, USA), anti-p-MEK(Ser217/221) (Cell Signaling technology, USA), anti-ERK1/2 (Cell Signaling technology), anti-p-ERK1/2 (Thr202/Tyr204) (Cell signaling technology), anti-p-H3S10 (Cell signaling technology), and anti-beta-actin (Sigma) antibodies. The reaction was followed by probing with peroxidase-coupled secondary antibodies and then detected by enhanced chemiluminescence (Amersham Pharmacia, USA).
###end p 37
###begin title 38
Statistical Analysis
###end title 38
###begin p 39
###xml 63 65 63 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t </italic>
Densitometry data were represented as fold increase. Student's t test was used to analyze the comparisons of differences, and p = 0.01 was considered significant.
###end p 39
###begin title 40
Results
###end title 40
###begin title 41
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
Detection of Aurora-A overexpression accompanied with Ha-ras mutation in bladder cancers
###end title 41
###begin p 42
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1D</xref>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 699 702 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 738 742 738 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
Aurora-A overexpression accompanied with Ha-ras codon 12 mutation has been reported in bladder cancers [41]. In this study, Ha-rasV12 mutation was detected in the tumour part of the bladder cancer specimen by SNP-real-time PCR and verified by sequence analysis (Figure 1A, Gly12 -> Val 12). The Aurora-A protein overexpression was detected in the same cancer part of the bladder tissue compared to the normal part by IHC staining (Figure 1B, T vs. N). Similarly, Ki-ras codon 12 mutation and higher expression level of Aurora-A were only detected in the cancer part of the colon tissue (Figure 1C and 1D). Taken together, despite of the difference in transformation of NIH3T3 cells by Ki-ras and Ha-ras, overexpression of Aurora-A and RasV12 (Ki- or Ha-) mutations are simultaneously detected in various cancers including bladder and colon.
###end p 42
###begin p 43
###xml 0 109 0 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Detection of Ha- and Ki-RasG12V mutation and overexpression of Aurora-A in bladder and colon cancer specimens</bold>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
Detection of Ha- and Ki-RasG12V mutation and overexpression of Aurora-A in bladder and colon cancer specimens. (A) Sequence analysisof Ha-ras codon 12 mutations of bladder cancer specimen shows the Gly12 to Val12 mutation of Ha-ras gene. (B) Aurora-A protein expression in bladder cancer (T) and normal tissue (N) was detected by IHC staining using anti-Aurora-A specific antibody. (C) Sequence analysisof Ki-ras codon 12 mutations of colon cancer specimen shows the Gly12 to Val12 mutation of Ki-ras gene. (D) Aurora-A protein expression in colon cancer (T) and normal tissue (N). " * " indicates the mutation site of ras gene. The pink arrow points the expression of Aurora-A by IHC stain.
###end p 43
###begin title 44
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
Establishment of stable cell lines over-expressing Aurora-A and mutant RasV12
###end title 44
###begin p 45
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 332 335 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 335 339 335 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 436 439 436 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 439 443 439 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 1210 1214 1210 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 1312 1314 1312 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 1346 1348 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 1383 1385 1383 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 741 746 <span type="species:ncbi:10090">mouse</span>
It is intriguing to unravel the combined effects of Aurora-A and mutant RasV12 on the morphological change and tumorigenesis of the cells. Stable cell lines were established by transfecting Vector DNA, wild-type Aurora-A or kinase-inactivated Aurora-A into 7-4 cells, which was derived from NIH/3T3 cells harboring the inducible Ha-rasV12 oncogene [23], designated Vector, WT and KD cell line, respectively. The expression levels of Ha-rasV12 in Vector, WT and KD cells in the presence of IPTG were much higher compared to the cells without IPTG (Figure 2A). Aurora-A can physically interact with the tail of Histone H3 (H3) and efficiently phosphorylates H3 at serine10 [45-48]. In addition, activation of ERK pathway in Ha-ras transformed mouse fibroblasts increases the level of p-H3S10. Consistently, our data showed the level of phosphorylated H3S10 (p-H3S10 detected by anti-p-H3S10 antibody) in WT cells (Figure 2A, lane 2, 1.8 fold) was higher than in Vector cells (Figure 2A, lane 1, 1.0 fold) and KD cells (Figure 2A, lane 3, 0.9 fold) in the absent of IPTG where Ras was not overexpressed. Our data showed that the Aurora-A overexpressed in WT cells is functional. In the presence of IPTG, where RasV12 protein was overexpressed, the level of phosphorylated H3S10 was increased both in Vector (Figure 2A, lane 4, 2.8 fold), WT (Figure 2A, lane 5, 3.8 fold) and KD (Figure 2A, lane 6, 2.8 fold) cells.
###end p 45
###begin p 46
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stable overexpression of wild-type or kinase-dead Aurora-A in WT and KD cells</bold>
###xml 610 611 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 104 109 <span type="species:ncbi:9606">human</span>
Stable overexpression of wild-type or kinase-dead Aurora-A in WT and KD cells. (A) Expression levels of human Aurora-A protein (wild-type: WT; kinase-inactivated: KD) and Ras in the Vector, WT and KD cells were detected by western blot analysis using anti-Aurora-A and anti-Ras specific antibodies. beta-actin was used as the equal loading control. The levels of p-H3S10 protein were quantified by a densitometer. The expression level of p-H3S10 in Vector cells without IPTG induction was set as 1.0 fold. (B) Morphology of Vector, WT and KD cells with or without IPTG induction. (C) Upper panel: Cells (5 x 102) were grown in 10 cm culture dishes with or without IPTG inductionfor two weeks. The foci were stained using Giemsa stain. Lower panel: Quantitative foci numbers of Vector, WT and KD cells with or without IPTG induction. (D) Growth curve of cell lines was measured daily for 5 days using MTT assay. The experiments were conducted in triplicate and repeated three times.
###end p 46
###begin p 47
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2C</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2C</xref>
###xml 527 531 527 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
Biological activity analysis showed that WT cells over-expressing wild-type Aurora-A became rounded and formed aggregates in the presence of IPTG compared to the Vector cells and KD cells (Figure 2B). Transforming analysis showed that WT cells form more foci compared to Vector and KD cells (Figure 2C). Despite the fact that focus numbers were also increased in the other two cell lines, a further increase of focus number in WT cells was observed after IPTG induction (Figure 2C). Taken together, both Aurora-A and mutant RasV12 overexpression can induce focus formation. Further induction of focus formation was detected when these two genes were overexpressed simultaneously.
###end p 47
###begin p 48
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2D</xref>
Cell proliferation analysis showed that WT cells grew slower than Vector and KD cells in the absence of IPTG. Growth rate of Vector, WT and KD cells were decreased when mutant Ras was overexpressed (Fig. 2D). The increase of cell aggregation of WT cells in the presence of IPTG was independent of cell growth rate.
###end p 48
###begin title 49
###xml 118 122 118 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
Aurora-A overexpression increases phosphorylation status of MEK/ERK and AKT as well as the activity of RalA in the RasV12 transformants
###end title 49
###begin p 50
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 451 455 451 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
To clarify the effects of Aurora-A on the signaling pathways related to Ras overexpression, three downstream signaling pathways of Ras, Raf/MEK, PI3K/AKT and RalGDS/Ral A were investigated. The phosphorylation of MEK (p-MEK) was higher in WT cells (Figure 3A, lane 2, 1.7 fold) than that in Vector (Figure 3A, lane 1, 1.0 fold) and KD cells (Figure 3A, lane 3, 0.8 fold). P-MEK levels in each cell line were further increased after IPTG induction (RasV12 is over-expressed) (Figure 3A, lane 4, 5, and 6). The same phenomenon was also been observed in p-ERK1/2 (Figure 3A). These results indicated that Aurora-A may further increase Ras induced MEK/ERK phosphorylation.
###end p 50
###begin p 51
###xml 92 96 92 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 0 109 0 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wild-type Aurora-A increases phosphorylation of MEK/ERK, AKT and the activity of RalA of Ras<sup>V12 </sup>transformants</bold>
Wild-type Aurora-A increases phosphorylation of MEK/ERK, AKT and the activity of RalA of RasV12 transformants. (A) The phosphorylation of MEK was detected by anti-p-MEK antibody. The expression levels of AKT and p-AKT were detected using anti-AKT and anti-p-AKT specific antibodies.Ral A activity was detected by Ral pull-down assay. The expression level of each protein in three cells was shown graphically at the bottom panel. (B) After Aurora-A siRNA (5 mug) was transfected into WT cells for 6 h, IPTG was added and incubated for another 48 h. The total cell lysates (100 mug) were separated by 12% SDS-PAGE. Ral A, Ras, Aurora-A and beta-actin were detected using Western blotting. The level of each protein was quantified by a densitometer. The expression level of each protein in Vector cells without IPTG induction was set as 1.0 fold. " * ": p <== 0.01
###end p 51
###begin p 52
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 302 306 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 459 463 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 575 578 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
The effect of Aurora-A on the PI3K/AKT pathway was evaluated by detecting phosphorylation of AKT (p-AKT). The p-AKT level was also higher in WT cells (Figure 3A, lane 2, 2.1 fold) compared to Vector and KD cells (Figure 3A, lane 1, 1.0 fold and lane 3, 1.1 fold, respectively). Upon IPTG induction, RasV12 overexpression increased the level of p-AKT in Vector and KD cells (Figure 3A, lane 4, 1.8 fold and lane 6, 2.1 fold, respectively). Co-expression of RasV12 and wild-type Aurora-A in WT cells increases the level of p-AKT (Figure 3A, lane 5, 3.5 fold) as compared to RasV12overexpression alone (Figure 3A, lane 4, 1.8 fold).
###end p 52
###begin p 53
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 346 350 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 416 420 416 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 491 495 491 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 563 567 563 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 702 706 702 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
The RalGDS/RalA signaling pathway was determined by detecting the activity of RalA using GST-RalBD pull-down assay. As shown in Figure 3A, Aurora-A overexpression alone activated RalA (Figure 3A, lane 2, 2.0 fold) as compared to the parental Vector cells (Figure 3A, lane 1, 1.0 fold). After IPTG induction, The RalA activity was increased by RasV12 overexpression (Figure 3A, lane 4, 2.5 fold). Co-expression of RasV12 and wild-type Aurora-A in WT cells increase the activity of RalA of RasV12 (Figure 3A, lane 5, 3.7 fold). Taken together, both Aurora-A and RasV12 increased the levels of p-MEK, pERK1/2, and p-AKT and the activation of RalA. This induction was further enhanced when Aurora-A and RasV12 were overexpressed simultaneously.
###end p 53
###begin p 54
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
To further confirm our results, Aurora-A specific small interference RNA (siRNA) was used. As shown in Figure 3B, Aurora-A specific siRNA decreased the expression level of Aurora-A in WT cells. Accordingly, levels of p-MEK/p-ERK, p-AKT and activation of RalA were also decreased when Aurora-A siRNA was introduced into WT cells upon IPTG induction. Our results confirmed that wild-type-Aurora-A enhance Ras downstream signaling pathways including MEK/ERK, AKT and RalA.
###end p 54
###begin title 55
The MEK/ERK pathway is involved in WT cell aggregation
###end title 55
###begin p 56
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 951 955 951 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 1021 1023 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1376 1378 1376 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1436 1438 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
The involvement of MEK/ERK, PI3K/AKT and RalGDS/RalA signaling pathways in Aurora-A-related cell aggregation (Fig. 2B, WT + IPTG) was clarified by treatment of the cells with the following inhibitors: FTI-277, a farnesylation inhibitor of Ras; PD-98059, the inhibitor of MEK kinase and LY-294002, the inhibitor of PI3K kinase and RalASa94A, a mutant of Ral. FTI-277 restrains Ras protein as a non-farnesylated form and inhibits p-ERK1/2 expression dose-dependently but had no effect on p-AKT (Figure 4A, lanes 2 and 3). PD-98059 decreased the phosphorylation of ERK1/2 (p-ERK1/2) but had no effect on other signaling pathways (Figure 4A, lanes 4 and 5). LY-294002 reduced the phosphorylation of AKT (p-AKT) but had no effect on another signaling pathway (Figure 4A, lanes 6 and 7). In summary, in WT cells Aurora-A increases the expression of p-ERK1/2 in a Ras dependent manner. However, FTI-277 does not reduce the p-AKT in WT cells co-expressing RasV12 and wild-type Aurora-A. Wild-type Aurora-A activates RalA (Figure 3A and 3B) and phosphorylates RalA at serine194 to promote cellular transformation and migration [38]. To reveal the role of RalA phosphorylation at ser194 in Aurora-A induced RalA activation in WT cells, the mutants RalAS183A or RalAS194A were transiently transfected into WT cells and the RalA activity was evaluated. Consistent with a previous report [38], only RalAS194A could reduce the Ral A activity (Figure 4B, lane 3).
###end p 56
###begin p 57
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The MEK/ERK pathway is involved in the aggregation of WT cells</bold>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 484 485 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 790 791 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
The MEK/ERK pathway is involved in the aggregation of WT cells. (A) Cells(5 x 105) were seeded in 60 mm plates. After IPTG induction for 24 h, the signaling pathway inhibitors were added and incubated for another 24 h. The p-ERK, ERK, p-AKT, AKT, Ras, Aurora-A and beta-actin were detected by western blotting. The level of each protein was quantified by a densitometer. The expression level of each protein in Vector cells without IPTG induction was set as 1.0 fold. (B) Cells(5 x 105) were seeded in 60 mm plates.After transfection of WT cells for 6 h with pHA-Vector (5 mug), pHA-RalA183A (5 mug) or pHA-RalA194A (5 mug), IPTG was added and incubated for another 48 h. The total cell lysates (500 mug) were used to detect the activity of Ral A by Ral A pull-down assay. (C) Cells (5 x 105) were seeded in 60 mm plates. After IPTG induction for 24 h, the inhibitors were added and incubated for another 24 h. For Aurora-A RNAi and RalAS194A, after transfection of cells for 6 h with Aurora-A siRNA (5 mug) or pHA-RalA194A (5 mug), IPTG was added and incubated for another 48 h. a.WT cells treated with IPTG. b.WT cells treated with IPTG/Aurora-A siRNA c.WT cells treated with IPTG/FTI-277 d.WT cells treated with IPTG/PD98059 e.WT cells treated with IPTG/LY294002 f.WT cells treated with IPTG/pHA-RalA194A. FTI-277, a farnesylation inhibitor of Ras; PD98059, an inhibitor of MEK kinase; LY294002, an inhibitor of PI3K kinase.
###end p 57
###begin p 58
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
To determine which signaling pathway is involved in the aggregation of WT cells during RasV12 overexpression, we first demonstrated that Aurora-A induced cell aggregation was blocked by Aurora-A specific small interfering RNA (Figure 4C). The WT cells were treated with FTI-277, PD-98059 or LY-294002 for 24 h and cell aggregation was observed. Both FTI-277 and PD98059 reversed the aggregation of WT cells, whereas LY-294002 showed no effect on cell aggregation (Figure 4C). Because mutant RalAS194A was unable to block cell aggregation, its role in Aurora-A induced cell aggregation was excluded (Figure 4C). Taken together, the Ras/MEK/ERK signaling pathway but not the PI3K/AKT or RalGDS/RalA pathway is responsible for Aurora-A induced cell aggregation.
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 885 889 885 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
Overexpression of an oncogene such as ras may cause senescence of transformed cells, and this event can be reversed by overexpression of a second oncogene such as c-myc, and Twst1/2 [49,50]. Aurora-A can promote the cell transformation of Ha-ras transformed BALB/c 3T3 A31-1-1 cells [39]. The nuclear EGFR induced by EGF associates with Stat5 to bind and increase Aurora-A gene expression, which ultimately leads to chromosome instability and tumorigenesis [51]. We previously reported that oncogenic Ras-induced morphological changes (from spindle-shaped to round) occur through the MEK/ERK signaling pathway to down-regulate Stat3 at a posttranslational level in NIH3T3 cells. Microtubule disruption is involved in the morphologic changes, which can be reversed by overexpression of Stat3 [52]. In this study, we determine that overexpression of wild-type-Aurora-A can enhance Ha-rasV12 transformant aggregation through the MEK/ERK signaling pathway.
###end p 60
###begin p 61
###xml 48 54 48 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12S35</sup>
###xml 211 217 211 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12S35</sup>
###xml 366 373 366 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12G37 </sup>
###xml 386 393 386 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12C40 </sup>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 928 932 928 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 1043 1044 1043 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1167 1168 1167 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 1003 1008 <span type="species:ncbi:9606">human</span>
The effector domain mutant of oncogenic Ras, RasV12S35, which specifically activates the Raf/MEK/ERK pathway in transformed NIH3T3 cells, can induce subcutaneous tumor formation and lung metastases. In these RasV12S35-transformed NIH 3T3 cells, high levels of activated ERK1/2 were detected. By contrast, the cells derived from the other effector domain mutants, RasV12G37 (PI3K) or RasV12C40 (RalGDS), did not show changes at the level of ERK1/2 activation and tumor metastasis [53]. The increase of ERK1/2 activation could lead to enhanced expression of many proteolysis enzymes such as the matrix metalloprotease (MMP) family genes which can degrade extracellular matrix, leading to increased cell invasiveness [54,55]. Furthermore, Aurora-A-regulated epithelial-mesenchymal transition and invasion are mediated by mitogen-activated protein kinase (MAPK) phosphorylation [58]. Our current and previous studies reveal that RasV12 mutation and Aurora-A overexpression can be detected simultaneously in human bladder and colon cancers (Figure 1). Co-expression of wild-type Aurora-A and mutant Ras enhances the signaling of the MEK/ERK, AKT and RalA activity (Figure 3). I
###end p 61
###begin p 62
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 1300 1309 1300 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 1385 1387 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 1388 1390 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 1589 1591 1589 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">as</italic>
###xml 1591 1595 1591 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
The activation of ERK1/2 requires phosphorylation of the conserved tyrosine and threonine residues by dual specific MAPK kinases (MEK), which are activated by the serine/threonine kinase Raf through phosphorylation. Scaffolding proteins such as MEK partner (MPI) or kinase suppressor of Ras (KSR) enhance the MEK/ERK signaling pathway in response to different stimuli [36,56-66]. The KSR/MEK complex is recruited to the membrane following dephosphorylation by phosphatase 2A (PP2A) at the Ser392 residue leading to release 14-3-3 from KSR and then exposes the C1 domain, which is required for the membrane localization of KSR, as well as the FxFP MAPK binding site. At the membrane, Raf-1 is activated and KSR provides a platform for the phosphorylation/activation of associated MEK and ERK [62,65]. Other proteins might help recruit activated Raf, triggering MEK phosphorylation. PP2A also interacts with Aurora-A [67]. Whether the PP2A may regulate Aurora-A and KSR complex to affect the MEK/ERK signaling pathway is valuable to explore. In addition, Aurora-A interacts with the other tumor suppressor RASSF1A. Aurora-A phosphorylates RASSF1A at Threonine202 and/or Serine203. Knockdown of RASSF1A reduces Aurora-A activation; however, the recombinant RASSF1A can not activate recombinant Aurora-A in vitro suggesting that RASSF1A may function as a scaffold for Aurora-A activation [68,69]. The possibility of the interaction between Aurora-A and KSR or RASSF1A requires more investigation and the involvement of other unidentified factor(s) in ERK1/2 activation induced by Aurora-A in RasV12 transformants can not be excluded.
###end p 62
###begin p 63
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 407 411 407 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
PI3K/AKT is a down stream signaling pathway of Ras. In Figure 3A, RasV12 or Wild-type Aurora-A alone increases the p-AKT level (Figure 3A, lane 2 and 4) and further increase p-AKT while both of the genes were overexpressed (Figure 3A, lane 5). However, upon FTI-277 treatment, the p-AKT level was not reduced in WT cell when RasV12 was overexpressed (Figure 4A, lane 2 and 3). Above results suggest that RasV12 and wild-type Aurora-A may share a redundant pathway to increase p-AKT expression level. Nonetheless, the underlying mechanism is unclear.
###end p 63
###begin p 64
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 485 488 485 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 488 492 488 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
Overexpression of Aurora-A induces cell motility of MDCK cells, mediated by RalA activation through phosphorylation of the serine 194 residue of RalA [38]. In the present study, we demonstrated that overexpression of either Aurora-A or mutant Ras stimulates RalA activation and maximal RalA activation is observed when both of the oncogenes are overexpressed (Fig. 3A, lane 5). However, we found that the RalAS194A mutant could not block cell aggregation induced by Aurora-A in the Ha-rasV12 transformants indicating that different signaling pathways may be transduced to control motility and aggregation of the different cells.
###end p 64
###begin p 65
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
In summary, our data demonstrate that aberrant Aurora-A expression plus ras mutation may occur simultaneously in various cancers, and the increase of MEK/ERK activation triggered by over-expression of the two oncogenes induces cell aggregation. We speculate that this event may play a pivotal role in Ras or Aurora-A related tumor progression.
###end p 65
###begin title 66
Conclusions
###end title 66
###begin p 67
###xml 37 41 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12 </sup>
Taken together, both Aurora-A and RasV12 mutant can activate the MEK/ERK1/2 signaling pathway. Our study reveals that additional activation of ERK1/2 may induce cell aggregation and increase cell focus formation when both oncogenes are overexpressed together. The results suggest that increased risk of tumor progression is possible through increase of ERK1/2 phosphorylation by diverse oncogenes.
###end p 67
###begin title 68
Competing interests
###end title 68
###begin p 69
The authors declare that they have no competing interests.
###end p 69
###begin title 70
Authors' contributions
###end title 70
###begin p 71
YST participated in conceptualization, carried out this study, and drafted the manuscript; JCL participated in the collection of cancer tissues; CYFH provided the Aurora-A wild and kinase dead plasmids as well as RalAS194A and RalAS183A plasmids. HSL conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript.
###end p 71
###begin title 72
Pre-publication history
###end title 72
###begin p 73
The pre-publication history for this paper can be accessed here:
###end p 73
###begin p 74

###end p 74
###begin title 75
Acknowledgements
###end title 75
###begin p 76
We thank Dr. Robert Anderson for critical reading of the manuscript. This work was supported by grants from Landmark Project Grant A25 of the NCKU funded by the Ministry of education in Taiwan and NSC-96-2628-B-006-003-MY3.
###end p 76
###begin article-title 77
Mitotic kinases as regulators of cell division and its checkpoints
###end article-title 77
###begin article-title 78
Chromosomal passengers and the (aurora) ABCs of mitosis
###end article-title 78
###begin article-title 79
The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis
###end article-title 79
###begin article-title 80
Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases
###end article-title 80
###begin article-title 81
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 121 131 <span type="species:ncbi:7227">Drosophila</span>
###xml 136 141 <span type="species:ncbi:4932">yeast</span>
Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1
###end article-title 81
###begin article-title 82
###xml 58 63 <span type="species:ncbi:9606">human</span>
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer
###end article-title 82
###begin article-title 83
###xml 18 23 <span type="species:ncbi:9606">human</span>
Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft
###end article-title 83
###begin article-title 84
###xml 15 25 <span type="species:ncbi:7227">Drosophila</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
###end article-title 84
###begin article-title 85
Overexpression and amplification of Aurora-A in hepatocellular carcinoma
###end article-title 85
###begin article-title 86
###xml 93 98 <span type="species:ncbi:9606">human</span>
Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers
###end article-title 86
###begin article-title 87
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas
###end article-title 87
###begin article-title 88
Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival
###end article-title 88
###begin article-title 89
###xml 86 91 <span type="species:ncbi:9606">human</span>
The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas
###end article-title 89
###begin article-title 90
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation
###end article-title 90
###begin article-title 91
###xml 57 62 <span type="species:ncbi:9606">human</span>
Amplification/overexpression of a mitotic kinase gene in human bladder cancer
###end article-title 91
###begin article-title 92
Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast
###end article-title 92
###begin article-title 93
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
###end article-title 93
###begin article-title 94
###xml 17 22 <span type="species:ncbi:9606">human</span>
Ras oncogenes in human cancer: a review
###end article-title 94
###begin article-title 95
Understanding Ras: 'it ain't over 'til it's over'
###end article-title 95
###begin article-title 96
The dark side of Ras: regulation of apoptosis
###end article-title 96
###begin article-title 97
Increasing complexity of Ras signaling
###end article-title 97
###begin article-title 98
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 60 77 60 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli </italic>
###xml 60 76 <span type="species:ncbi:562">Escherichia coli</span>
Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements
###end article-title 98
###begin article-title 99
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells
###end article-title 99
###begin article-title 100
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras</italic>
###xml 6 12 6 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val12 </sup>
Ha-rasVal12 oncogene increase susceptibility of NIH/3T3 cells to lovastatin
###end article-title 100
###begin article-title 101
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
Selective activation of Ha-ras (val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha
###end article-title 101
###begin article-title 102
Ha-ras overexpression mediated cell apoptosis in the presence of 5-fluorouracil
###end article-title 102
###begin article-title 103
Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors
###end article-title 103
###begin article-title 104
elk-1 proteins interact with MAP kinases
###end article-title 104
###begin article-title 105
elk-1 domains responsible for autonomous DNA binding, SRE: SRF interaction and negative regulation of DNA binding
###end article-title 105
###begin article-title 106
###xml 26 29 <span type="species:ncbi:9860">Elk</span>
The SRF accessory protein Elk-1 contains a growth factor regulated transcription domain
###end article-title 106
###begin article-title 107
###xml 26 29 <span type="species:ncbi:9860">Elk</span>
###xml 132 135 <span type="species:ncbi:9860">Elk</span>
The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1
###end article-title 107
###begin article-title 108
The Ras branch of small GTPases: Ras family members don't fall far from the tree
###end article-title 108
###begin article-title 109
###xml 37 44 <span type="species:ncbi:8355">Xenopus</span>
The kinase Eg2 is a component of the Xenopus oocyte progesterone-activated signaling pathway
###end article-title 109
###begin article-title 110
The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1
###end article-title 110
###begin article-title 111
Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway
###end article-title 111
###begin article-title 112
KSR is a scaffold required for activation of the ERK/MAPK module
###end article-title 112
###begin article-title 113
Identification of Aurora kinases as RasGAP Src homology 3 domain-binding proteins
###end article-title 113
###begin article-title 114
Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening
###end article-title 114
###begin article-title 115
Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis
###end article-title 115
###begin article-title 116
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
###end article-title 116
###begin article-title 117
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer
###end article-title 117
###begin article-title 118
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene
###end article-title 118
###begin article-title 119
Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway
###end article-title 119
###begin article-title 120
Ras-dependent activation of the small GTPase Ral
###end article-title 120
###begin article-title 121
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis
###end article-title 121
###begin article-title 122
Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation
###end article-title 122
###begin article-title 123
###xml 77 84 <span type="species:ncbi:8355">Xenopus</span>
pEg2 aurora-A kinase, histone H3 phosphorylation, and chromosome assembly in Xenopus egg extract
###end article-title 123
###begin article-title 124
Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases
###end article-title 124
###begin article-title 125
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ras </italic>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene
###end article-title 125
###begin article-title 126
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence
###end article-title 126
###begin article-title 127
Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression
###end article-title 127
###begin article-title 128
Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate Stat3 at a posttranslational level in NIH3T3 cells
###end article-title 128
###begin article-title 129
Signaling pathways in Ras-mediated tumorigenicity and metastasis
###end article-title 129
###begin article-title 130
Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration
###end article-title 130
###begin article-title 131
PD 09 an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma
###end article-title 131
###begin article-title 132
###xml 77 82 <span type="species:ncbi:4932">yeast</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human
###end article-title 132
###begin article-title 133
Organization and regulation of mitogen-activated protein kinase signaling pathways
###end article-title 133
###begin article-title 134
Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
###end article-title 134
###begin article-title 135
Phosphorylation of MAP kinases by MAP/ERK involves multiple regions of MAP kinases
###end article-title 135
###begin article-title 136
Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo
###end article-title 136
###begin article-title 137
MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade
###end article-title 137
###begin article-title 138
Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites
###end article-title 138
###begin article-title 139
KSR--a regulator and scaffold protein of the MAPK pathway
###end article-title 139
###begin article-title 140
Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation
###end article-title 140
###begin article-title 141
MAP kinase module: the Ksr connection
###end article-title 141
###begin article-title 142
Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK
###end article-title 142
###begin article-title 143
Functional Interaction of Auror-A and PP2A during Mitosis
###end article-title 143
###begin article-title 144
Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation
###end article-title 144
###begin article-title 145
RASSF1A interacts with and activates the mitotic kinase Aurora-A
###end article-title 145

